0001989478-23-000002.txt : 20230828 0001989478-23-000002.hdr.sgml : 20230828 20230828123336 ACCESSION NUMBER: 0001989478-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230828 DATE AS OF CHANGE: 20230828 EFFECTIVENESS DATE: 20230828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Superluminal Medicines, Inc. CENTRAL INDEX KEY: 0001989478 IRS NUMBER: 883006168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490789 FILM NUMBER: 231212953 BUSINESS ADDRESS: STREET 1: 200 BERKELEY ST., 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (301) 525-8752 MAIL ADDRESS: STREET 1: 200 BERKELEY ST., 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001989478 Superluminal Medicines, Inc. 200 BERKELEY ST., 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 (301) 525-8752 DELAWARE Superluminal Medicines, LLC None Corporation true 2023 CONY D'CRUZ c/o 200 BERKELEY ST., 18th FL. BOSTON MA MASSACHUSETTS 02116 Executive Officer Director Promoter ANDREW LEVIN c/o 200 BERKELEY ST., 18th FL. BOSTON MA MASSACHUSETTS 02116 Director DYLAN MORRIS c/o 200 BERKELEY ST., 18th FL. BOSTON MA MASSACHUSETTS 02116 Director CATHERINE RIESEN c/o 200 BERKELEY ST., 18th FL. BOSTON MA MASSACHUSETTS 02116 Executive Officer CRAIG RANDALL c/o 200 BERKELEY ST., 18th FL. BOSTON MA MASSACHUSETTS 02116 Executive Officer Biotechnology Decline to Disclose 06b false 2023-03-03 false true false 0 25679107 25679107 0 false 7 0 0 0 false Superluminal Medicines, Inc. /s/ Cony DCruz Cony DCruz Chief Executive Officer 2023-08-28